TNIP1 Antibody - C-terminal region : FITC (ARP61714_P050-FITC)

TNIP1 interacts with zinc finger protein A20/TNFAIP3 and inhibits TNF-induced NF-kappa-B-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal. TNIP1 increases cell surface CD4 (T4) antigen expression. TNIP1 interacts with HIV-1 matrix protein and is packaged into virions and overexpression can inhibit viral replication. TNIP1 may regulate matrix nuclear localization, both nuclear import of PIC (Preintegration complex) and export of GAG polyprotein and viral genomic RNA during virion production.

HDDC3; MAGEB18; CFAP53; TXLNA; CCDC112; MOB3C; SYT6; TCEANC2; MOB1B; MAP1LC3A; NIFK; FAM161A; MAP1LC3B; TNIP3; SNIP1; CDIP1; NME7; MAGEH1; GABARAPL2; PNKP; MORF4L1; RALBP1; ZNHIT1; NDC80; TNIP1; OPTN; MORF4L2; AP1M1; TAX1BP1; ZBTB25; UBC; TNFAIP3; TCEA2

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.